These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 30006690)
1. Triple Mapping to Optimize Axillary Management in Breast Cancer Patients After Neoadjuvant Therapy. Shilad S; Cakmakoglu C; Schwarz G; Valente S; Djohan R; Grobmyer S Ann Surg Oncol; 2018 Oct; 25(10):3106. PubMed ID: 30006690 [No Abstract] [Full Text] [Related]
2. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes. Foster D; Choy N; Porter C; Ahmed S; Wapnir I J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459 [TBL] [Abstract][Full Text] [Related]
4. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy. Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751 [TBL] [Abstract][Full Text] [Related]
5. Lymphatic mapping and sentinel lymph node biopsy in breast cancer patients: a comprehensive review of variations in performance and technique. Newman LA J Am Coll Surg; 2004 Nov; 199(5):804-16. PubMed ID: 15501123 [No Abstract] [Full Text] [Related]
6. Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer. Lawson LL; Sandler M; Martin W; Beauchamp RD; Kelley MC Am Surg; 2004 Dec; 70(12):1050-5; discussion 1055-6. PubMed ID: 15663043 [TBL] [Abstract][Full Text] [Related]
7. Lymphatic mapping techniques and sentinel lymph node biopsy in breast cancer. Newman EA; Newman LA Surg Clin North Am; 2007 Apr; 87(2):353-64, viii. PubMed ID: 17498531 [TBL] [Abstract][Full Text] [Related]
8. Axillary reverse mapping in breast cancer: a new microsurgical lymphatic-venous procedure in the prevention of arm lymphedema. Casabona F; Bogliolo S; Ferrero S; Boccardo F; Campisi C Ann Surg Oncol; 2008 Nov; 15(11):3318-9. PubMed ID: 18709416 [No Abstract] [Full Text] [Related]
9. Sentinel lymph node detection by intranipple injection of patent blue dye in breast cancer: a preliminary report of a feasibility study. Zervoudis S; Iatrakis G; Paschopoulos M; Dousias V; Geahchan N; Stefos T; Pechlivani F; Navrozoglou I Eur J Gynaecol Oncol; 2012; 33(3):304-5. PubMed ID: 22873105 [TBL] [Abstract][Full Text] [Related]
10. Concordance between peri-areolar blue dye and peri-incisional radiotracer injections for sentinel node mapping in patients with a history of primary breast cancer excisonal biopsy. Mehrabibahar M; Azizi S; Jangjoo A; Saremi E; Kakhki VR; Sadeghi R; Chicken DW; Keshtgar M Acta Chir Belg; 2014; 114(1):31-3. PubMed ID: 24720135 [TBL] [Abstract][Full Text] [Related]
12. [Lymphatic mapping in axilla as possible prevention of lymphedema in breast cancer patients - first results of the anatomical study]. Pavlista D; Eliška O Ceska Gynekol; 2012 Jun; 77(3):251-4. PubMed ID: 22779729 [TBL] [Abstract][Full Text] [Related]
13. Axillary reverse mapping using fluorescence imaging is useful for identifying the risk group of postoperative lymphedema in breast cancer patients undergoing sentinel node biopsies. Sakurai T; Endo M; Shimizu K; Yoshimizu N; Nakajima K; Nosaka K; Dai Y; Iwao A; Jinnai Y J Surg Oncol; 2014 May; 109(6):612-5. PubMed ID: 24310418 [TBL] [Abstract][Full Text] [Related]
14. Factors affecting sentinel lymph node detection failure in breast cancer patients using intradermal injection of the tracer. Abdollahi A; Jangjoo A; Dabbagh Kakhki VR; Rasoul Zakavi S; Memar B; Naser Forghani M; Mehrabibahar M; Sadeghi R Rev Esp Med Nucl; 2010; 29(2):73-7. PubMed ID: 19931946 [TBL] [Abstract][Full Text] [Related]
15. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes. Lin KM; Patel TH; Ray A; Ota M; Jacobs L; Kuvshinoff B; Chung M; Watson M; Ota DM J Am Coll Surg; 2004 Oct; 199(4):561-6. PubMed ID: 15454139 [TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy for breast cancer. Bold RJ; Schlieman M; Fahy BN Cancer Biother Radiopharm; 2001 Oct; 16(5):347-57. PubMed ID: 11776752 [TBL] [Abstract][Full Text] [Related]
17. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Thompson M; Korourian S; Henry-Tillman R; Adkins L; Mumford S; Westbrook KC; Klimberg VS Ann Surg Oncol; 2007 Jun; 14(6):1890-5. PubMed ID: 17479341 [TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy after neoadjuvant systemic chemotherapy in patients with breast cancer: a prospective pilot trial. Medina-Franco H; Salgado-Nesme N; Zerón-Medina-Cuairán J Rev Invest Clin; 2008; 60(5):390-4. PubMed ID: 19227436 [TBL] [Abstract][Full Text] [Related]
19. The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies. Han C; Yang B; Zuo WS; Zheng G; Yang L; Zheng MZ PLoS One; 2016; 11(2):e0150285. PubMed ID: 26919589 [TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy in breast cancer: results of intradermal periareolar tracer injection and follow-up of sentinel lymph node-negative patients. van Wessem KJ; Meijer WS Breast; 2004 Aug; 13(4):290-6. PubMed ID: 15325663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]